Prevalence of 308 tumor necrosis factor α polymorphism (TNF1, G at position 308; and TNF2, A at position 308), according to subject group
| Subject group . | TNF1/TNF1 . | TNF1/TNF2 . | TNF2/TNF2 . |
|---|---|---|---|
| Controls (n = 172) | 134 (77) | 38 (22) | 2 (1) |
| Patients with HHC (n = 64) | 49 (77) | 15 (23) | 0 |
| C282Y +/+ patients (n = 38) | 29 (76) | 9 (24) | 0 |
| Non-C282Y +/+ patients (n = 26) | 20 (77) | 6 (23) | 0 |
| Subject group . | TNF1/TNF1 . | TNF1/TNF2 . | TNF2/TNF2 . |
|---|---|---|---|
| Controls (n = 172) | 134 (77) | 38 (22) | 2 (1) |
| Patients with HHC (n = 64) | 49 (77) | 15 (23) | 0 |
| C282Y +/+ patients (n = 38) | 29 (76) | 9 (24) | 0 |
| Non-C282Y +/+ patients (n = 26) | 20 (77) | 6 (23) | 0 |
Values are number (%) in each group.
See Tables 1 and 2 for abbreviations.